Summit Overview
22 - 23 Jun 2026 Boston, MA, United States and Virtual
The 2026 ISPE AI in Life Sciences Summit – Powered by GAMP® will bring together pharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights, and provide an outlook on artificial intelligence in the life sciences industry.
This conference will focus on the transformative role of artificial intelligence across the life sciences value chain, including drug or device development, clinical research, manufacturing, supply chain management, and post-market surveillance, and covering business, quality, and technology perspectives. The Summit will feature industry and regulatory keynotes and panel discussions sharing high-level perspectives on innovation, strategy, and regulatory expectations.
Unlock your potential with Continuing Education!
Invest in your future! Join us at the 2026 ISPE AI in Life Sciences Summit to enhance your skills, share ideas, connect with peers, and earn 1.2 CEUs. Start your journey towards lifelong learning and career advancement today!
Your Summit Experience
Expo Hall
Expo Hall
Explore groundbreaking innovations and network with industry leaders at our dynamic expo hall.
Professional Training
Professional Training
Connect with top industry experts and expand your professional network at our exclusive networking sessions.
Keynote Speakers
Keynote Speakers
Subject matter experts and top leaders in the pharmaceutical industry.
Summit Sessions
Summit Sessions
Learn from industry experts.
+
6
Networking Hours
+
11
Education Hours
+
35
Exhibitors
Summit Highlight
Maturing AI in Life Sciences: Building Infrastructure, Not Experiments
Artificial intelligence is no longer confined to innovation labs within life sciences organizations. It is now influencing drug and device development, clinical research, manufacturing operations, supply chain performance, and post-market surveillance. AI systems are accelerating molecule screening, enhancing pharmacovigilance signal detection, optimizing maintenance programs, and supporting documentation workflows.
International Program Committee
Chair
Associate Director, Operational Readiness and QCORE
IPS
Board Liaison
Global Head of Quality & Compliance
Roche / Genentech
Chapter Liaison
Manager, Customer Success
NECI
Head of Lifecycle Management, Innovation, and Strategy
Takeda Pharmaceuticals
Senior Executive Consultant
Q-FINITY Quality Management
Vice President, Corporate Quality
Syneos Health
Senior Director of CMC Policy & Advocacy
Alnylam
Founder | Managing Partner
The Triality Group, LLC
CMC Reg Policy Manufacturing Innovation
F. Hoffman-La Roche AG
Global Head, Regulatory Affairs
AbbVie, Inc.
Emerging Leader
Associate Director
Eli Lilly and Co